These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7977967)

  • 1. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas.
    Boyle JO; Mao L; Brennan JA; Koch WM; Eisele DW; Saunders JR; Sidransky D
    Am J Surg; 1994 Nov; 168(5):429-32. PubMed ID: 7977967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas.
    Henderson YC; Wang E; Clayman GL
    Laryngoscope; 1998 Oct; 108(10):1553-6. PubMed ID: 9778300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas.
    Liao PH; Chang YC; Huang MF; Tai KW; Chou MY
    Oral Oncol; 2000 May; 36(3):272-6. PubMed ID: 10793330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutations as markers of tumor spread in synchronous oral cancers.
    Koch WM; Boyle JO; Mao L; Hakim J; Hruban RH; Sidransky D
    Arch Otolaryngol Head Neck Surg; 1994 Sep; 120(9):943-7. PubMed ID: 8074821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between p53 mutation and cyclin D1 amplification in had and neck squamous cell carcinoma.
    Mineta H; Borg A; Dictor M; Wahlberg P; Wennerberg J
    Oral Oncol; 1997 Jan; 33(1):42-6. PubMed ID: 9192552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
    Koch WM; Brennan JA; Zahurak M; Goodman SN; Westra WH; Schwab D; Yoo GH; Lee DJ; Forastiere AA; Sidransky D
    J Natl Cancer Inst; 1996 Nov; 88(21):1580-6. PubMed ID: 8901856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck.
    Temam S; Flahault A; Périé S; Monceaux G; Coulet F; Callard P; Bernaudin JF; St Guily JL; Fouret P
    J Clin Oncol; 2000 Jan; 18(2):385-94. PubMed ID: 10637254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases.
    Tjebbes GW; Leppers vd Straat FG; Tilanus MG; Hordijk GJ; Slootweg PJ
    Oral Oncol; 1999 Jul; 35(4):384-9. PubMed ID: 10645403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of ras oncogene mutations in human squamous cell carcinoma of the head and neck.
    Núñez F; Domínguez O; Coto E; Suárez-Nieto C; Pérez P; López-Larrea C
    Surg Oncol; 1992 Dec; 1(6):405-11. PubMed ID: 1341278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 mutations in upper aerodigestive squamous cell carcinomas from a group of Brazilian patients.
    Nagai MA; Miracca EC; Yamamoto L; Kowalski LP; Brentani RR
    Am J Surg; 1995 Nov; 170(5):492-4. PubMed ID: 7485740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.
    Brennan JA; Boyle JO; Koch WM; Goodman SN; Hruban RH; Eby YJ; Couch MJ; Forastiere AA; Sidransky D
    N Engl J Med; 1995 Mar; 332(11):712-7. PubMed ID: 7854378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
    Sisk EA; Soltys SG; Zhu S; Fisher SG; Carey TE; Bradford CR
    Head Neck; 2002 Sep; 24(9):841-9. PubMed ID: 12211048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens.
    Balz V; Scheckenbach K; Götte K; Bockmühl U; Petersen I; Bier H
    Cancer Res; 2003 Mar; 63(6):1188-91. PubMed ID: 12649174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
    Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
    J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene mutations in oral carcinomas from India.
    Munirajan AK; Tutsumi-Ishii Y; Mohanprasad BK; Hirano Y; Munakata N; Shanmugam G; Tsuchida N
    Int J Cancer; 1996 May; 66(3):297-300. PubMed ID: 8621246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the p53 gene status of lymph node metastasis in the head and neck region in occult primary cancer].
    Gottschlich S; Schuhmacher O; Görögh T; Hoffmann M; Maune S
    Laryngorhinootologie; 2000 Jul; 79(7):434-7. PubMed ID: 11005098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
    Brachman DG; Graves D; Vokes E; Beckett M; Haraf D; Montag A; Dunphy E; Mick R; Yandell D; Weichselbaum RR
    Cancer Res; 1992 Sep; 52(17):4832-6. PubMed ID: 1324797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions.
    van Houten VM; Tabor MP; van den Brekel MW; Denkers F; Wishaupt RG; Kummer JA; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2000 Oct; 6(10):3803-16. PubMed ID: 11051222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.